[Septicemia due to candida albicans. Pathogenesis, diagnosis, and chemotherapy].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000935:Antifungal Agents / Q000627:therapeutic use; D000985:Antisepsis; D001555:Benzene Derivatives / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D002176:Candida albicans / Q000032:analysis / Q000254:growth & development / Q000472:pathogenicity; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy; D002404:Catheterization / Q000009:adverse effects; D004197:Disease Reservoirs; D004987:Ethers / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000382:microbiology; D010587:Phagocytosis; D018805:Sepsis / Q000209:etiology*; D014680:Veins
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D001555:Benzene Derivatives; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D005437:Flucytosine
Candida-albicans-Sepsis. Pathogenese, Nachweis und Chemotherapie